Trends in county-level childhood vaccination exemptions in the US
Peer-Reviewed Publication
Updates every hour. Last Updated: 3-Jun-2026 20:16 ET (4-Jun-2026 00:16 GMT/UTC)
Salk scientists discover the immune system handles infection differently in young and aged mice with sepsis, with the same immune responses that are advantageous in youth being disadvantageous in older age. The findings suggest therapies should be tailored to age-specific responses, with young and old patients receiving different optimized treatment plans, and also may help inform alternative treatment strategies as we enter a post-antibiotic era.
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple workflow. A team of researchers from Genomill Health Inc., the University of Turku, and the TYKS Turku University Hospital, Finland, benchmarked this new method, Bridge Capture, against two market-leading tools Their analysis, appearing in The Journal of Molecular Diagnostics, published by Elsevier, highlights the method’s simplicity, cost-efficiency, reproducibility, and scalability, making it well suited for routine clinical testing, disease monitoring, and treatment selection.
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer will experience a lasting response to a newly approved immunotherapy called tarlatamab. The findings, which are published in Cancer Discovery, could allow clinicians to easily and noninvasively determine which patients should receive the drug.